Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Common Stock
PROF | US
6.99
USD0.24
3.56%
PROF | US
Loading StockChartView...
About Common Stock
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
24/04/2026
Close
6.99
Open
6.75
High
7.18
Low
6.51
Profound Medical Corp. together with its subsidiaries operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada Germany the United States and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI) robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise flexible and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve which combines real-time MRI and thermometry for the treatment of uterine fibroids palliative pain treatment of bone metastases and osteoid osteoma. Profound Medical Corp. is headquartered in Mississauga Canada.
View LessPROF | US
Risk
77.4
Sharpe
0.57
Luna's Score
54/100
Recommendation
Hold
Luna says (PROF | US)
What's Working
Positive Momentum
Strength based on increasing price with high volume
Strong Revenue Growth (> 10%)
What's not Working
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
68.9%1 month
77.4%3 months
87.7%6 months
77.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
4.83
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
-5.75
Ent. to rev.
20.62
PEG
-
Other Fundamentals
EBITDA
-29.97M
MarketCap
171.80M
MarketCap(USD)
171.80M
Div. yield
-
Op. margin
-350.78
Erngs. growth
-
Rev. growth
39.40
Ret. on equity
-66.00
Short ratio
4.65
Short perc.
2.71
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.38
Range1M
2.03
Range3M
3.35
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.01
Price X volume
1.30M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -5.75 | 12.67 | Cheaper |
| Ent. to Revenue | 20.62 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 4.83 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 87.71 | 59.59 | Riskier |
| Debt to Equity | - | -14.36 | - |
| Debt to Assets | - | 0.34 | - |
| Market Cap | 171.80M | 13.71B | Emerging |
